“This is welcome news for our local and international clients”, said Dr. M. Mancini, Labofine’s Director of Corporate Development, “since it increases our capacity to provide storage conditions for long-term, accelerated or intermediate studies for the three classes of label storage claims and the conditions required by the five climatic zones meeting ICH and WHO guidelines.”
“By adding state-of-the-art equipment, we are beyond excited to continue building momentum with our expansion, which we believe is an excellent representation of the way Labofine views our partnerships with our customers,” added CEO Dr. G. Sammane.
Labofine first entered the Canadian testing market in 2014 with the opening of its Laval, Quebec location. Since then, it has seen tremendous growth, including the opening of operations in California in 2017 to offer extensive coverage of the North American market. After joining the Tentamus Group in 2019, Labofine continues to expand its reach to better serve its Canadian customers in the domain of supplements, pharmaceuticals, cosmetics and food products.
Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China, Japan, India and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food & feed, pharmaceuticals & medical, agrosciences, cosmetics, agriculture & environment and nutraceutical & supplements). Tentamus Group is represented in over 65 locations worldwide. More than 2,500 highly-trained staff members work in over 2.5 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.
Tentamus Group GmbH
An der Industriebahn 26
13088 Berlin
Telefon: +49 (30) 206038-230
Telefax: +49 (30) 206038-190
http://www.tentamus.com
Customer Service Manager Labofine
E-Mail: rosanne@labofine.com
